Am J Med

1. POWER MC, Madsen M, Bodkergaard K, Zimmerman SC, et al
   Early glycemic control and subsequent risk of incident dementia among new metformin users.
   Am J Med. 2026;139:321-332.
   

   >> Share

   
   

   
   Ann Intern Med

2. KO A, Chang YC, Bahar F, Wang TH, et al
   Risk for Cancer With Glucagon-Like Peptide-1 Receptor Agonists and Dual Agonists : A Systematic Review and Meta-analysis.
   Ann Intern Med. 2026;179:216-229.
   

   >> Share

   
   

   
   BMJ

3. WISE J
   Type 2 diabetes: SGLT-2 inhibitors should be offered as first line treatment, doctors are told.
   BMJ. 2026;392:s333.
   

   >> Share

   
   

   
   Circ Heart Fail

4. KARDYS I
   Beneath the Surface: Unraveling the Proteomics of Diabetes-Related Heart Failure.
   Circ Heart Fail. 2026 Feb 17:e014166. doi: 10.1161/CIRCHEARTFAILURE.126.014166.
   

   >> Share

   
   

   
   Diabet Med

5. MCINERNEY AM, Schmitz N, Matthews M, Deschenes SS, et al
   The impact of sleep and movement behaviour on daily mood in people with type 2 diabetes: A smartphone-based digital phenotyping study.
   Diabet Med. 2026 Feb 19:e70269. doi: 10.1111/dme.70269.
   

   >> Share

   
   
6. CARDOSO CRL, Castro GP, Leite NC, Salles GF, et al
   Prognostic value of triglyceride-derived metabolic parameters for micro- and macrovascular complications and mortality in individuals with type 2 diabetes: The Rio de Janeiro type 2 diabetes cohort study.
   Diabet Med. 2026 Feb 19:e70263. doi: 10.1111/dme.70263.
   

   >> Share

   
   
7. SANFILIPPO S, Muller A, Aberer F, Aziz F, et al
   Decision accuracy of simultaneously used real-time CGM versus intermittently scanned CGM around exercise in type 1 diabetes: A secondary analysis of the ULTRAFLEXI-1 study.
   Diabet Med. 2026 Feb 18:e70267. doi: 10.1111/dme.70267.
   

   >> Share

   
   
8. MANSBRIDGE SE, Kozlowska O, Lumb A, Rea R, et al
   A multi-centre qualitative study of experiences of managing diabetes mellitus among adults while hospitalised.
   Diabet Med. 2026 Feb 18:e70256. doi: 10.1111/dme.70256.
   

   >> Share

   
   
9. DAVIS TME, Davis WA
   Refining insights on type 2 diabetes and aortic valve replacement-reply to Liu et al.
   Diabet Med. 2026 Feb 18:e70266. doi: 10.1111/dme.70266.
   

   >> Share

   
   
10. LIU P, He X, Song Z
    Refining insights on type 2 diabetes and aortic valve replacement.
    Diabet Med. 2026 Feb 18:e70239. doi: 10.1111/dme.70239.
    

    >> Share

    
    
11. MORSLI M, Magnan C, Salipante F, Dubois A, et al
    Enhancing diabetic foot osteomyelitis diagnosis with metagenomics next-generation sequencing, proof of concept.
    Diabet Med. 2026 Feb 15:e70235. doi: 10.1111/dme.70235.
    

    >> Share

    
    
12. XIANG Q, Wang S, Miao Y, Fu Z, et al
    Trends in global risk factors for the development of type 2 diabetes mellitus: Evidence from the global burden of disease study, 1990-2021.
    Diabet Med. 2026 Feb 15:e70217. doi: 10.1111/dme.70217.
    

    >> Share

    
    
13. SANCHEZ-GARCIA D, Luna-Garza Y, Saavedra-Castillo E, Gomez-Martinez G, et al
    Effect of liraglutide on subclinical atherosclerosis and cardiometabolic risk factors in adults with type 1 diabetes: A prospective pilot study.
    Diabet Med. 2026 Feb 15:e70222. doi: 10.1111/dme.70222.
    

    >> Share

    
    

    
    Diabetes

14. VOGT EL, Kowaltowski AJ
    GLP-1, Pancreatic beta-Cells, and Insulin Secretion: What We Know and Where We Need to Go.
    Diabetes. 2026;75:403-413.
    

    >> Share

    
    
15. FABRICIOVA V, Bohuslavova R, Lebron-Mora L, Slaninova V, et al
    ISL1 Restricts Progenitor Programs and Promotes beta-Cell Maturation, Revealing Sex Differences in Diabetes Progression.
    Diabetes. 2026 Feb 17:db250673. doi: 10.2337/db25-0673.
    

    >> Share

    
    
16. TONG S, Peng C, Xiong Y, Lei J, et al
    GDF5 Exacerbates Tubulointerstitial Injury by Inducing Partial Epithelial-Mesenchymal Transition of Tubular Epithelial Cells in Diabetic Kidney Disease.
    Diabetes. 2026 Feb 17:db250599. doi: 10.2337/db25-0599.
    

    >> Share

    
    
17. XIANG Z, Zitian L, Guangwei Y, Shuohui D, et al
    Activation of the Pancreatic "Metabolic Synapse" Aggravates Type 2 Diabetes Mellitus by Inducing PANoptosis in beta-Cells.
    Diabetes. 2026 Feb 17:db250863. doi: 10.2337/db25-0863.
    

    >> Share

    
    
18. BOSE M, Mohan M, Okabe J, Kaipananickal H, et al
    Epigenetic Regulation of VCAM-1 by Lipoxin A4 Is Renoprotective Against Diabetic Kidney Disease.
    Diabetes. 2026 Feb 18:db250970. doi: 10.2337/db25-0970.
    

    >> Share

    
    
19. PAGE B
    Diabetes Spotlight: Martin Myers, MD, PhD-Understanding Metabolism and Glucose Through Neural Networks.
    Diabetes. 2026;75:399-400.
    

    >> Share

    
    

    
    Diabetes Care

20. O'HARA NN, O'Hara LM, Roghmann MC
    Response to comment on O'Hara et al. Understanding Patient Preferences Regarding Limb Salvage for Diabetic Foot Ulcers: A Discrete Choice Experiment. Diabetes Care 2025;48:1517-1523.
    Diabetes Care. 2026;49:e59.
    

    >> Share

    
    
21. VAN DER MEER R, Pazmino S, Steenackers N, van Laar A, et al
    Impact of Metabolic Bariatric Surgery on Weight Loss and Glycemic Control in Adults With Type 1 Diabetes: A Multicenter Retrospective Cohort Study.
    Diabetes Care. 2026 Feb 18:dc252295. doi: 10.2337/dc25-2295.
    

    >> Share

    
    
22. REED SD
    Comment on O'Hara et al. Understanding Patient Preferences Regarding Limb Salvage for Diabetic Foot Ulcers: A Discrete Choice Experiment. Diabetes Care 2025;48:1517-1523.
    Diabetes Care. 2026;49:e58.
    

    >> Share

    
    
23. HUDSON JI, Hudson MS, Schatzberg AF
    Comment on Buse et al. Prevalence of Hypercortisolism in Difficult-to-Control Type 2 Diabetes. Diabetes Care 2025;48:2012-2020.
    Diabetes Care. 2026;49:e55.
    

    >> Share

    
    
24. HASEBE M, Su CY
    Comment on Sun et al. SGLT2i Versus Metformin for Delirium Prevention in Type 2 Diabetes: A Real-World, Head-to-Head Comparative Study. Diabetes Care 2025;48:1361-1369.
    Diabetes Care. 2026;49:e66-e67.
    

    >> Share

    
    
25. NOH Y, Yin H, Ben Ghezala I, Yu OHY, et al
    Glucagon-Like Peptide 1 Receptor Agonists and Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients With Type 2 Diabetes.
    Diabetes Care. 2026 Feb 17:dc252577. doi: 10.2337/dc25-2577.
    

    >> Share

    
    
26. WANG Y, Bullard KM, Zhang P
    National Trends in Expenditures on Glucose-Lowering Medications in U.S. Adults With Diabetes: 2000-2022.
    Diabetes Care. 2026 Feb 17:dc252016. doi: 10.2337/dc25-2016.
    

    >> Share

    
    
27. KORAKAS E, Kountouri A, Pliouta L, Petrovski G, et al
    780G Hybrid Closed-Loop Pump as Adjunct to Metreleptin in Lipodystrophy-Associated Diabetes: Three Case Observations.
    Diabetes Care. 2026 Feb 17:dc252407. doi: 10.2337/dc25-2407.
    

    >> Share

    
    
28. MONTASER E, Williams C, Shah VN
    Assessing Time Below Range as a Predictor of Severe Hypoglycemia: Insights From Six Clinical Trials.
    Diabetes Care. 2026;49:483-489.
    

    >> Share

    
    
29. NIU F, Liu M, Yovanovich C, Vigersky RA, et al
    MiniMed 780G Advanced Hybrid Closed-Loop System Use During Days Without User-Initiated Boluses.
    Diabetes Care. 2026;49:419-425.
    

    >> Share

    
    
30. HUNG CH, Lin CT, Wei JC
    Comment on Sun et al. SGLT2i Versus Metformin for Delirium Prevention in Type 2 Diabetes: A Real-World, Head-to-Head Comparative Study. Diabetes Care 2025;48:1361-1369.
    Diabetes Care. 2026;49:e68.
    

    >> Share

    
    
31. PAGE B
    About the Editor: Mark Atkinson, PhD-A Leading Voice in Type 1 Diabetes Research.
    Diabetes Care. 2026;49:364.
    

    >> Share

    
    
32. WANG B, Huang J, Chen Z
    On Prognostication Versus Screening: A Critical Appraisal of Natriuretic Peptide Testing in Diabetes.
    Diabetes Care. 2026;49:e62-e63.
    

    >> Share

    
    
33. QI MM, Wang MM
    Comment on Pop-Busui et al. Screening Natriuretic Peptide Levels Predicts Heart Failure and Death in Individuals With Type 1 and Type 2 Diabetes Without Known Heart Failure. Diabetes Care 2025;48:2145-2153.
    Diabetes Care. 2026;49:e60-e61.
    

    >> Share

    
    
34. BUSE JB, Kahn SE, Schlafly TK, Einhorn D, et al
    Response to comment on Buse et al. Prevalence of Hypercortisolism in Difficult-to-Control Type 2 Diabetes. Diabetes Care 2025;48:2012-2020.
    Diabetes Care. 2026;49:e56-e57.
    

    >> Share

    
    
35. POP-BUSUI R, Repetto E, Baron J, Schumacher D, et al
    Response to comments on Pop-Busui et al. Screening Natriuretic Peptide Levels Predicts Heart Failure and Death in Individuals With Type 1 and Type 2 Diabetes Without Known Heart Failure. Diabetes Care 2025;48:2145-2153.
    Diabetes Care. 2026;49:e64-e65.
    

    >> Share

    
    
36. POWE CE, Simmons D
    Eighteen to Twenty Weeks' Gestation: Not the Right Time to Screen for Gestational Diabetes Mellitus.
    Diabetes Care. 2026;49:375-377.
    

    >> Share

    
    
37. JACOBSEN LM, Sims EK
    Going From Stage 2 to Stage 3 Type 1 Diabetes-Does Not Matter How You Got Here.
    Diabetes Care. 2026;49:378-380.
    

    >> Share

    
    
38. DAVE D, Steinhubl SR, McQueen RB
    Deep Learning-Enabled Diabetic Retinopathy Screening: A Techno-Clinical Revolution or Just More Artificial Intelligence Hype?
    Diabetes Care. 2026;49:381-383.
    

    >> Share

    
    

    
    Diabetes Obes Metab

39. YANG Z, Jiao Y, Sun Y, Wu Y, et al
    Associations of metformin and sulfonylurea on vascular complications in early- and late-onset type 2 diabetes: A cohort study.
    Diabetes Obes Metab. 2026 Feb 18. doi: 10.1111/dom.70564.
    

    >> Share

    
    
40. ZHOU X, Lu J, Wang Z, Cheng KK, et al
    Causal role of genetically predicted impairment of branched-chain amino acid catabolism on insulin secretion and insulin resistance in type 2 diabetes.
    Diabetes Obes Metab. 2026 Feb 18. doi: 10.1111/dom.70565.
    

    >> Share

    
    
41. TAN RJL, Ahuja A, Shrestha A, Gallen G, et al
    A retrospective observational study evaluating the safety and effectiveness of commercially available automated insulin delivery systems in people with type 1 diabetes and gastroparesis.
    Diabetes Obes Metab. 2026 Feb 19. doi: 10.1111/dom.70575.
    

    >> Share

    
    
42. 
    Correction to "Efficacy and safety in tirzepatide-treated Korean adults with type 2 diabetes-A post hoc analysis of SURPASS-AP-combo and SURPASS-3".
    Diabetes Obes Metab. 2026 Feb 19. doi: 10.1111/dom.70591.
    

    >> Share

    
    
43. TEOH H, Verma S, Mancini GBJ, Quan A, et al
    Evaluation of evolocumab on saphenous vein graft patency following coronary artery bypass graft surgery in people living with and without diabetes in the NEWTON-CABG CardioLink-5 trial.
    Diabetes Obes Metab. 2026 Feb 19. doi: 10.1111/dom.70590.
    

    >> Share

    
    
44. HU J, Ge T, Zhu Q, Yao Y, et al
    Association between the oxidative balance score and risk of microvascular complications in type 2 diabetes: A prospective UK biobank cohort study.
    Diabetes Obes Metab. 2026 Feb 18. doi: 10.1111/dom.70566.
    

    >> Share

    
    
45. WU Y, Feng K, Fu Y, Zhuo Q, et al
    Unveiling glycaemic variability patterns linked to the triglyceride-glucose index in type 2 diabetes: Insights from continuous glucose monitoring.
    Diabetes Obes Metab. 2026 Feb 18. doi: 10.1111/dom.70558.
    

    >> Share

    
    
46. TONG X, Xing C, Zhang L, Zhang L, et al
    Cost-utility of once-weekly insulin icodec versus once-daily basal insulins for type 2 diabetes in China.
    Diabetes Obes Metab. 2026 Feb 18. doi: 10.1111/dom.70567.
    

    >> Share

    
    
47. TRAN RH, Raghupathy P, Hazim M, Thompson E, et al
    Hepatic and abdominal adiposity in type 2 diabetes as assessed with machine learning on computed tomography scans.
    Diabetes Obes Metab. 2026 Feb 18. doi: 10.1111/dom.70557.
    

    >> Share

    
    
48. FOUNTOULAKIS N, Pavlou P, Stathi D, Goubar A, et al
    Effect of lixisenatide on arterial stiffness in people with type 2 diabetes and kidney disease: Results of a randomised controlled trial.
    Diabetes Obes Metab. 2026 Feb 18. doi: 10.1111/dom.70481.
    

    >> Share

    
    
49. ULRICH FS, Napoli N, Nielsen MF, Burden AM, et al
    Real-world persistence and dose titration of GLP-1 receptor agonists in type 2 diabetes: A UK population-based cohort study by obesity and cardiovascular disease status.
    Diabetes Obes Metab. 2026 Feb 17. doi: 10.1111/dom.70535.
    

    >> Share

    
    

    
    Diabetologia

50. MALTESE G, Karalliedde J, Dhesi J, Bellary S, et al
    Type 1 diabetes, ageing and frailty: an underexplored intersection.
    Diabetologia. 2026 Feb 17. doi: 10.1007/s00125-026-06681.
    

    >> Share

    
    
51. LUDVIGSSON J
    The rise and fall of a paradigm and conceiving a new hypothesis for type 1 diabetes. Reply to Nerup J, Lernmark A [letter].
    Diabetologia. 2026 Feb 17. doi: 10.1007/s00125-026-06689.
    

    >> Share

    
    

    
    J Clin Endocrinol Metab

52. XU X, Yang H, Yu C, Zhang W, et al
    Impact of Serum Prolactin on Cognitive Function, Brain Structure and Function in Type 2 Diabetes Mellitus.
    J Clin Endocrinol Metab. 2026 Feb 19:dgag067. doi: 10.1210.
    

    >> Share

    
    
53. GAO Y, Hsu V, Kil A, Arias M, et al
    Effect of Osteocalcin on Insulin Sensitivity, Insulin Secretion, and beta-cell Compensation in Mexican Americans.
    J Clin Endocrinol Metab. 2026;111:e937-e942.
    

    >> Share

    
    

    
    J Clin Invest

54. FILIP P, Canna A, Grohn H, Moheet AA, et al
    Disrupted Neurovascular-Endocrine Coupling in Type 1 Diabetes with impaired awareness of hypoglycaemia.
    J Clin Invest. 2026 Feb 19:e199725. doi: 10.1172/JCI199725.
    

    >> Share

    
    
55. HEROLD KC, Perdigoto AL
    Predicting checkpoint inhibitor-associated autoimmune diabetes: prospects and limitations.
    J Clin Invest. 2026;136:e202477.
    

    >> Share

    
    
56. KAHLES F, Birkenfeld AL, Marx N
    GLP-1 and the cardiovascular system.
    J Clin Invest. 2026;136:e194748.
    

    >> Share

    
    
57. JALLEH RJ, Talley NJ, Horowitz M, Nauck MA, et al
    The science of safety: adverse effects of GLP-1 receptor agonists as glucose-lowering and obesity medications.
    J Clin Invest. 2026;136:e194740.
    

    >> Share

    
    
58. AHMED A, Yadav P, Jensen M, Geasland K, et al
    Mitochondrial oxidants promote platelet activation and thrombotic susceptibility in prediabetes.
    J Clin Invest. 2025;136:e195662.
    

    >> Share

    
    

    
    J Diabetes Complications

59. D'ELIA JA, Roshan B, Weinrauch LA
    Mechanisms in diabetes mellitus: Relationships to metabolism and/or neoplasia.
    J Diabetes Complications. 2026;40:109289.
    

    >> Share

    
    
60. ZIORI M, Tentolouris A, Eleftheriadou I, Voudouri A, et al
    Corneal confocal microscopy and cardiac autonomic neuropathy in individuals with type 1 diabetes mellitus.
    J Diabetes Complications. 2026;40:109290.
    

    >> Share

    
    

    
    J Nutr

61. OFOKANSI MN, Agbo CE, Isiogugu ON, Onwuka AM, et al
    Antidiabetic Effect of Cyanidin-3-Glucoside: A Systematic Review of Animal Studies.
    J Nutr. 2026;156:101264.
    

    >> Share

    
    

    
    JAMA

62. JACOBSEN LM, Schatz DA
    Type 1 Diabetes: A Review.
    JAMA. 2026 Feb 16. doi: 10.1001/jama.2026.0048.
    

    >> Share

    
    
63. WALTER K
    What Is Type 1 Diabetes?
    JAMA. 2026 Feb 16. doi: 10.1001/jama.2026.0561.
    

    >> Share

    
    

    
    Metabolism

64. AMREIN K, Kim SH, Brath H, Fasching P, et al
    Mini-review. Vitamin D for the prevention of type 2 diabetes: Evidence and implications.
    Metabolism. 2026 Feb 16:156566. doi: 10.1016/j.metabol.2026.156566.
    

    >> Share

    
    

    
    Obstet Gynecol

65. WANG XY, Grobman WA, Wu J, Suzawa R, et al
    Patient-Led Insulin Titration for Glycemic Management With Gestational Diabetes Mellitus: A Randomized Controlled Trial.
    Obstet Gynecol. 2026 Feb 19. doi: 10.1097/AOG.0000000000006154.
    

    >> Share

    
    

    
    Ophthalmol Retina

66. RODRIGUES ALVES N, Barao C, Basilio A
    Vitreous Cyst from Retinal Hole in Proliferative Diabetic Retinopathy.
    Ophthalmol Retina. 2026 Feb 17:S2468-6530(26)00041.
    

    >> Share

    
    

    
    Pediatr Diabetes

67. LIN A, Jankowski M, Qu S, Uhley V, et al
    Association Between Celiac Disease and Uncontrolled Hemoglobin A1c Levels in Type 1 Diabetes Pediatric Patients.
    Pediatr Diabetes. 2026;2026:5225066.
    

    >> Share

    
    

    
    PLoS One

68. LE DH
    RWDisEnh+: Enhancing disease-enhancer association prediction through multiplex-heterogeneous networks.
    PLoS One. 2026;21:e0341861.
    

    >> Share

    
    
69. HAILU W, Dejene TA, Tiruneh M, Molla MD, et al
    Diabetic kidney disease in northwest Ethiopia: Prevalence and determinants among adults with type 2 diabetes.
    PLoS One. 2026;21:e0343210.
    

    >> Share

    
    
70. PAN J, Xue X, Li H, Wu L, et al
    Determinants of medication adherence and knowledge among patients with Type 2 diabetes mellitus: A cross-sectional study in Northwestern China.
    PLoS One. 2026;21:e0343091.
    

    >> Share

    
    
71. MUCHERINO S, Orlando V, Vervloet M, Weesie Y, et al
    Medication adherence trajectories and association with risk factors and clinical outcomes in type 2 diabetes treatment.
    PLoS One. 2026;21:e0342056.
    

    >> Share

    
    
72. MCGEEHAN L, Robbins MJ, Jurich D, Tucker S, et al
    Promoting equity on licensing exams: Test accommodations for medical students with diabetes.
    PLoS One. 2026;21:e0340975.
    

    >> Share

    
    
73. NAZARI M, Taheri M, Nouri F, Bahmanzadeh M, et al
    Synergistic effects of antibiotics and fucoidan on dual-species Staphylococcus aureus and Acinetobacter baumannii biofilm in diabetic rat wound models.
    PLoS One. 2026;21:e0342905.
    

    >> Share

    
    
74. 
    Retraction: Angiogenesis Impairment in Diabetes: Role of Methylglyoxal-Induced Receptor for Advanced Glycation Endproducts, Autophagy and Vascular Endothelial Growth Factor Receptor 2.
    PLoS One. 2026;21:e0343105.
    

    >> Share

    
    
75. SI C, Wu X, Cheng H, Jiang W, et al
    The immunopathological crosstalk of diabetic periodontitis: Single-cell insights into monocyte dysregulation.
    PLoS One. 2026;21:e0341333.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share